These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 7878715)
1. Prevention of transfusion-associated Chagas' disease by sterilization of Trypanosoma cruzi-infected blood with gentian violet, ascorbic acid, and light. Ramirez LE; Lages-Silva E; Pianetti GM; Rabelo RM; Bordin JO; Moraes-Souza H Transfusion; 1995 Mar; 35(3):226-30. PubMed ID: 7878715 [TBL] [Abstract][Full Text] [Related]
2. Strategies for prevention of transfusion-associated Chagas' disease. Moraes-Souza H; Bordin JO Transfus Med Rev; 1996 Jul; 10(3):161-70. PubMed ID: 8809967 [TBL] [Abstract][Full Text] [Related]
3. Prevention of Chagas' disease resulting from blood transfusion by treatment of blood: toxicity and mode of action of gentian violet. Docampo R; Moreno SN; Gadelha FR; de Souza W; Cruz FS Biomed Environ Sci; 1988 Dec; 1(4):406-13. PubMed ID: 3151757 [TBL] [Abstract][Full Text] [Related]
4. Treatment of T. cruzi infected human platelet concentrates with aminomethyltrimethyl psoralen (AMT) and ultraviolet A (UV-A) light: preliminary results. Moraes-Souza H; Bordin JO; Bardossy L; Blajchman MA Rev Soc Bras Med Trop; 1996; 29(1):47-9. PubMed ID: 8851215 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of the cytotoxicity of crystal violet against Trypanosoma cruzi in the blood by ascorbate. Docampo R; Moreno SN; Cruz FS Mol Biochem Parasitol; 1988 Jan; 27(2-3):241-7. PubMed ID: 2830513 [TBL] [Abstract][Full Text] [Related]
6. Prevention of transfusion-associated Chagas' disease: efficacy of white cell-reduction filters in removing Trypanosoma cruzi from infected blood. Moraes-Souza H; Bordin JO; Bardossy L; MacPherson DW; Blajchman MA Transfusion; 1995 Sep; 35(9):723-6. PubMed ID: 7570930 [TBL] [Abstract][Full Text] [Related]
7. Metabolism and preservation of fresh and stored erythrocytes in blood treated with gentian violet. Moraes-Souza H; Kerbauy J; Barretto OC; Pühler GM; Nonoyama K; Juliano Y Braz J Med Biol Res; 1988; 21(2):241-6. PubMed ID: 3144400 [TBL] [Abstract][Full Text] [Related]
8. [Chagas' disease and blood transfusion: trypanocidal activity of maprotiline hydrochloride and gentian violet]. Celentano AM; González Cappa SM Medicina (B Aires); 1988; 48(3):265-8. PubMed ID: 3150028 [No Abstract] [Full Text] [Related]
9. [Post-transfusion Chagas' disease]. Amato Neto V Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(3):135-7. PubMed ID: 3150608 [No Abstract] [Full Text] [Related]
10. A strategy for the prevention of the transmission of Chagas' disease during blood transfusion. Hammond DJ; Croft SL; Hogg J; Gutteridge WE Acta Trop; 1986 Dec; 43(4):367-78. PubMed ID: 2882664 [TBL] [Abstract][Full Text] [Related]
11. Potential use of WR6026 as prophylaxis against transfusion-transmitted American trypanosomiasis. Chiari E; Oliveira AB; Prado MA; Alves RJ; Galvão LM; Araujo FG Antimicrob Agents Chemother; 1996 Mar; 40(3):613-5. PubMed ID: 8851580 [TBL] [Abstract][Full Text] [Related]
12. [Hemotherapy and transfusional Chagas' disease in Brazil]. Moraes-Souza H; Wanderley DM; Brener S; Nascimento RD; Antunes CM; Dias JC Bol Oficina Sanit Panam; 1994 May; 116(5):406-18. PubMed ID: 8043200 [TBL] [Abstract][Full Text] [Related]
13. [Effect of gentian violet on Trypanosoma cruzi in vitro; importance in the sterilization of blood for transfusion]. NUSSENZWEIG V; BIANCALANA A; AMATO NETO V; SONNTAG R; DE FREITAS JP; KLOETZEL J Rev Paul Med; 1953 Jan; 42(1):57-8. PubMed ID: 13075109 [No Abstract] [Full Text] [Related]
16. Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Kirchhoff LV; Paredes P; Lomelí-Guerrero A; Paredes-Espinoza M; Ron-Guerrero CS; Delgado-Mejía M; Peña-Muñoz JG Transfusion; 2006 Feb; 46(2):298-304. PubMed ID: 16441610 [TBL] [Abstract][Full Text] [Related]
17. Aminoquinolone WR6026 as a feasible substitute for gentian violet in Chagas' disease prophylaxis in preserved blood for transfusional purposes. Moraes-Souza H; Pianetti GM; Barretto OC; Nonoyama K; Grolg M; Chiari E Rev Soc Bras Med Trop; 2002; 35(6):563-9. PubMed ID: 12612735 [TBL] [Abstract][Full Text] [Related]
18. High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina. Sánchez Negrette O; Mora MC; Basombrío MA Pediatrics; 2005 Jun; 115(6):e668-72. PubMed ID: 15930194 [TBL] [Abstract][Full Text] [Related]
19. Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood. Tonnetti L; Thorp AM; Reddy HL; Keil SD; Goodrich RP; Leiby DA Transfusion; 2012 Feb; 52(2):409-16. PubMed ID: 21827502 [TBL] [Abstract][Full Text] [Related]